Vaccine-induced or Hybrid immunity reduces re-infection chances for 9-10 months only
Despite a faster vaccination rate in Bhubaneswar, Khordha district lags behind the South Delhi district in the inoculation race. Infection rate in Cuttack is 0.01 percent, but fully vaccinated vis-a-vis the population is below 30 per cent.
India's Covid vaccination coverage has crossed 51 crores cumulatively.
Bharat Biotech plans to produce 200 million doses of Covaxin per annum in the GMP facilities that are already operational for the production of vaccines based on inactivated Vero Cell Platform Technology, under stringent levels of GMP and biosafety.
Following careful examination, the Drugs Controller General of India (DCGI) on Wednesday accepted the recommendation of Subject Expert Committee (SEC) and accorded permission to conduct the Phase II/III clinical trial of Covid-19 vaccine - Covaxin in the age group 2 to 18 years, to its manufacturer Bharat Biotech Ltd.
New Delhi: Eleven months after the first case of deadly coronavirus was detected in India, Drug Controller General of India (DCGI) V.G. Somani on Sunday approved Bharat Biotech’s ‘Covaxin’ and Serum Institute of India’s ‘Covishield’ vaccine for emergency use, paving the way for their roll-out and administration to millions. This is a major relief for […]
Bhubaneswar: The big story of the Day-4 in the vaccination drive against COVID19 in Odisha is the State’s Capital city Bhubaneswar has seemingly shed the initial ‘vaccine hesitancy’ to score an over the top performance today. The Capital stride assumes significance when the vaccination rate in the whole of the State on Wednesday has been […]
LIVE TV
